The cyclophilin inhibitor NIM-811 increases muscle cell survival with hypoxia in vitro and improves gait performance following ischemia–reperfusion in vivo

Khairat Bahgat Youssef El Baradie, Mohammad B. Khan, Bharati Mendhe, Jennifer Waller, Frederick O’Brien, Mark W. Hamrick

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'The cyclophilin inhibitor NIM-811 increases muscle cell survival with hypoxia in vitro and improves gait performance following ischemia–reperfusion in vivo'. Together they form a unique fingerprint.

Medicine & Life Sciences